|
WO2021026129A1
|
|
Compositions and methods for detecting sepsis
|
|
WO2020243616A1
|
|
E-cadherin activating antibodies and uses thereof
|
|
WO2020072996A1
|
|
Newborn screening for primary immunodeficiencies, cystinosis, and wilson disease
|
|
WO2019241721A2
|
|
Compositions and methods relative to igm memory b cells
|
|
US2019336573A1
|
|
Methods of treating kawasaki disease
|
|
WO2019210272A1
|
|
Ultrasound-mediated gene and drug delivery
|
|
CN112272565A
|
|
In vivo gene therapy using delivery of lentiviral gene constructs
|
|
EP3784790A1
|
|
Bruton's tyrosine kinase homing endonuclease variants, compositions, and methods of use
|
|
AU2019260754A1
|
|
Talen-based and crispr/cas-based gene editing for bruton's tyrosine kinase
|
|
AU2013221672A1
|
|
Bispecific chimeric antigen receptors and therapeutic uses thereof
|
|
AU2009233759A1
|
|
Broad-band, low frequency, high-amplitude, long time duration, oscillating airway pressure breathing apparatus and method utilizing bubbles
|
